This biodegradable and biocompatible filler is designed for facial volume restoration, wrinkle reduction, and tissue contouring. It offers tunable degradation, minimal granuloma risk, and potential for combination with biologics.

The global dermal filler market exceeds $5 billion annually and is projected to reach over $8 billion by 2030. Our injectable formulation is complete, supported by strong preclinical and clinical safety data, with infrastructure in place for scale-up.

Projected peak sales are $100 million per year.